Supreme Court to Review the Constitutionality of the PTO’s Inter Partes Review

In a case that may change how drug companies deal with patent infringement cases, the U.S. Supreme Court agreed to consider the constitutionality of the PTO’s inter partes review process, which allows the validity of patents to be challenged based on whether their claims are considered obvious at the time they are awarded.
Source: Drug Industry Daily